2-Aminoacetophenone as a potential breath biomarker for Pseudomonas aeruginosa in the cystic fibrosis lung.
about
Clinical application of volatile organic compound analysis for detecting infectious diseasesVolatile metabolites of pathogens: a systematic reviewDetecting bacterial lung infections: in vivo evaluation of in vitro volatile fingerprintsA quorum sensing small volatile molecule promotes antibiotic tolerance in bacteriaIdentification of anti-virulence compounds that disrupt quorum-sensing regulated acute and persistent pathogenicityIdentification of a Large Pool of Microorganisms with an Array of Porphyrin Based Gas SensorsBreath gas metabolites and bacterial metagenomes from cystic fibrosis airways indicate active pH neutral 2,3-butanedione fermentation.A quorum sensing regulated small volatile molecule reduces acute virulence and promotes chronic infection phenotypes.Molecular analysis of volatile metabolites released specifically by Staphylococcus aureus and Pseudomonas aeruginosa.The quorum sensing volatile molecule 2-amino acetophenon modulates host immune responses in a manner that promotes life with unwanted guests.Exhaled breath analysis using electronic nose in cystic fibrosis and primary ciliary dyskinesia patients with chronic pulmonary infections.A small volatile bacterial molecule triggers mitochondrial dysfunction in murine skeletal muscle.Electrochemistry provides a point-of-care approach for the marker indicative of Pseudomonas aeruginosa infection of cystic fibrosis patients.Robust detection of P. aeruginosa and S. aureus acute lung infections by secondary electrospray ionization-mass spectrometry (SESI-MS) breathprinting: from initial infection to clearance.Bacterial-excreted small volatile molecule 2-aminoacetophenone induces oxidative stress and apoptosis in murine skeletal muscle.Secondary electrospray ionization-mass spectrometry (SESI-MS) breathprinting of multiple bacterial lung pathogens, a mouse model study.Evidence for Direct Control of Virulence and Defense Gene Circuits by the Pseudomonas aeruginosa Quorum Sensing Regulator, MvfRA quorum-sensing signal promotes host tolerance training through HDAC1-mediated epigenetic reprogramming.The end of an old hypothesis: the pseudomonas signaling molecules 4-hydroxy-2-alkylquinolines derive from fatty acids, not 3-ketofatty acids.Oxidative modification of proteins in pediatric cystic fibrosis with bacterial infections.Halitology (breath odour: aetiopathogenesis and management).Recent analytical approaches to detect exhaled breath ammonia with special reference to renal patients.NF-κBp50 and HDAC1 Interaction Is Implicated in the Host Tolerance to Infection Mediated by the Bacterial Quorum Sensing Signal 2-Aminoacetophenone.Volatile organic compound detection as a potential means of diagnosing cutaneous wound infections.Mass spectrometric techniques for the analysis of volatile organic compounds emitted from bacteria.A rapid method for breath analysis in cystic fibrosis patients.Characteristics of volatile organic compounds produced from five pathogenic bacteria by headspace-solid phase micro-extraction/gas chromatography-mass spectrometry.Variability in the concentrations of volatile metabolites emitted by genotypically different strains of Pseudomonas aeruginosa.Comprehensive volatile metabolic fingerprinting of bacterial and fungal pathogen groups.Volatile molecules from bronchoalveolar lavage fluid can 'rule-in' Pseudomonas aeruginosa and 'rule-out' Staphylococcus aureus infections in cystic fibrosis patients.Olfactory experience primes the heat shock transcription factor HSF-1 to enhance the expression of molecular chaperones in C. elegans.Molecular Insights into Function and Competitive Inhibition of Pseudomonas aeruginosa Multiple Virulence Factor Regulator.The benefits of using solid-phase microextraction as a greener sample preparation technique.Direct Growth of Bacteria in Headspace Vials Allows for Screening of Volatiles by Gas Chromatography Mass Spectrometry.
P2860
Q26829695-7D13B825-85ED-4693-AACB-B3217E6F7411Q27001726-4AAD9A19-D2F8-4EA8-8DB2-864879BA22C2Q28283051-0D83B171-90C5-40C4-A27A-1E79307F9BADQ28537801-368381B0-FCC2-41B8-B279-344D2C2636A3Q28542505-EB3DF715-B4E0-4E54-9D23-0EF2C2CB79FFQ28833764-9D3A6A77-1CEE-40AD-9A09-A8021C161E39Q33647129-7EFEFA68-43A9-440E-869D-49FEDFC38A19Q33987501-2F552D53-612E-4CBD-AC11-1E3BA828EB64Q34310915-4A98B9C2-3DE1-415A-9466-EC879908ECE8Q34481845-4CFD0D27-7E28-49B5-9887-E8CB4AC786E0Q34776102-F7025C63-358D-41F5-BB42-CFC6C68958A5Q35009877-27B10488-D3A5-4D69-96B3-5F4133A52892Q35187639-DC0825D7-A84D-46FF-A10A-24B403BE38D9Q35586935-15B7CD49-9066-4E83-AAF1-3909CCB43166Q36684324-EF044A48-7FF3-43A6-B2DF-4D2FCE79417DQ36924171-0BA831CA-1779-4155-9559-7C00114EE2A9Q37291373-36C19825-F780-4141-ACD1-051035A53038Q37343778-7CA69F54-138D-4ECB-9CB5-78C6314ECBACQ37424462-7546F1FC-65B7-4661-A9CB-12DA9C512A7AQ37719105-37E73785-AD91-4E50-B21C-EEEA2EC9C800Q37978669-E0C0F1E7-F02D-4F4F-B776-386D5A568BAEQ38824229-C0AD77A1-3058-43EB-A42D-1A6C9D7D3EADQ39309715-6729A503-F5AC-4F00-BB01-541FAB008515Q39447497-3D91A6EB-F546-4D90-9C64-53B1D47FC625Q39454020-0EBFEAE5-B858-48F3-B3B8-CEBDC5C167F0Q41644928-562D5188-8677-4975-9218-FE9D86B94161Q46456125-5977C938-4DFE-4024-AAFA-FB73ED6D317FQ47587078-A14BD41B-4369-4ADF-96DE-44A187E37F9DQ47626949-427E4839-4295-43CA-9208-1F80C7CE3B0DQ47655373-63CB76AB-7A51-4A37-A3FC-79364B13A296Q48014097-09D1CD8A-98A3-4430-AA9B-BCB87BA03AA1Q50020529-2B4E02FE-D283-4DC2-98E9-0A15E236AB5AQ50494815-FDA0BB43-462E-445A-8EC0-0A5CD81F5877Q53409127-B250F426-5D20-4969-AF3C-BAEF4280C0C8
P2860
2-Aminoacetophenone as a potential breath biomarker for Pseudomonas aeruginosa in the cystic fibrosis lung.
description
2010 nî lūn-bûn
@nan
2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
2-Aminoacetophenone as a poten ...... a in the cystic fibrosis lung.
@ast
2-Aminoacetophenone as a poten ...... a in the cystic fibrosis lung.
@en
type
label
2-Aminoacetophenone as a poten ...... a in the cystic fibrosis lung.
@ast
2-Aminoacetophenone as a poten ...... a in the cystic fibrosis lung.
@en
prefLabel
2-Aminoacetophenone as a poten ...... a in the cystic fibrosis lung.
@ast
2-Aminoacetophenone as a poten ...... a in the cystic fibrosis lung.
@en
P2093
P2860
P921
P356
P1476
2-Aminoacetophenone as a poten ...... a in the cystic fibrosis lung.
@en
P2093
Amy J Scott-Thomas
John Pearson
Michael Epton
Mona Syhre
Philip K Pattemore
Richard Laing
Stephen T Chambers
P2860
P2888
P356
10.1186/1471-2466-10-56
P577
2010-11-07T00:00:00Z
P5875
P6179
1050430959